Report Detail
Global Cabazitaxel Market Growth 2019-2024
- RnM3035726 |
- 27 February, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Global cabazitaxel production regions are mainly distributed in USA and Europe. There is no doubt that USA is the largest production region in the world. In the future, we predict that there will be more and more cabazitaxel suppliers as soon as Sanofi’s Cabazitaxel patent expired. By 2024, global production will be 1427.4 Kg.
Currently, there are four major cabazitaxel API suppliers globally, including Sanofi, Tapi Teva, Fuan Pharmaceutical Group and Fujian Yewpark Biological etc. Sanofi is the global leader in this industry. According to our research, Sanofi had provided 845.8 Kg cabazitaxel API in 2017, which account for 95.32% of global market.
According to this study, over the next five years the Cabazitaxel market will register a 5.4% CAGR in terms of revenue, the global market size will reach US$ 230 million by 2024, from US$ 170 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cabazitaxel business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cabazitaxel market by product type, application, key manufacturers and key regions and countries.
This study considers the Cabazitaxel value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Age Below 65
Age Above 65
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cabazitaxel consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cabazitaxel market by identifying its various subsegments.
Focuses on the key global Cabazitaxel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cabazitaxel with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cabazitaxel submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cabazitaxel Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cabazitaxel Consumption 2014-2024
- 2.1.2 Cabazitaxel Consumption CAGR by Region
- 2.2 Cabazitaxel Segment by Type
- 2.2.1 Type I
- 2.2.2 Type II
- 2.3 Cabazitaxel Consumption by Type
- 2.3.1 Global Cabazitaxel Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Cabazitaxel Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Cabazitaxel Sale Price by Type (2014-2019)
- 2.4 Cabazitaxel Segment by Application
- 2.4.1 Age Below 65
- 2.4.2 Age Above 65
- 2.5 Cabazitaxel Consumption by Application
- 2.5.1 Global Cabazitaxel Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Cabazitaxel Value and Market Share by Application (2014-2019)
- 2.5.3 Global Cabazitaxel Sale Price by Application (2014-2019)
3 Global Cabazitaxel by Players
- 3.1 Global Cabazitaxel Sales Market Share by Players
- 3.1.1 Global Cabazitaxel Sales by Players (2017-2019)
- 3.1.2 Global Cabazitaxel Sales Market Share by Players (2017-2019)
- 3.2 Global Cabazitaxel Revenue Market Share by Players
- 3.2.1 Global Cabazitaxel Revenue by Players (2017-2019)
- 3.2.2 Global Cabazitaxel Revenue Market Share by Players (2017-2019)
- 3.3 Global Cabazitaxel Sale Price by Players
- 3.4 Global Cabazitaxel Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Cabazitaxel Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Cabazitaxel Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Cabazitaxel by Regions
- 4.1 Cabazitaxel by Regions
- 4.1.1 Global Cabazitaxel Consumption by Regions
- 4.1.2 Global Cabazitaxel Value by Regions
- 4.2 Americas Cabazitaxel Consumption Growth
- 4.3 APAC Cabazitaxel Consumption Growth
- 4.4 Europe Cabazitaxel Consumption Growth
- 4.5 Middle East & Africa Cabazitaxel Consumption Growth
5 Americas
- 5.1 Americas Cabazitaxel Consumption by Countries
- 5.1.1 Americas Cabazitaxel Consumption by Countries (2014-2019)
- 5.1.2 Americas Cabazitaxel Value by Countries (2014-2019)
- 5.2 Americas Cabazitaxel Consumption by Type
- 5.3 Americas Cabazitaxel Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cabazitaxel Consumption by Countries
- 6.1.1 APAC Cabazitaxel Consumption by Countries (2014-2019)
- 6.1.2 APAC Cabazitaxel Value by Countries (2014-2019)
- 6.2 APAC Cabazitaxel Consumption by Type
- 6.3 APAC Cabazitaxel Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cabazitaxel by Countries
- 7.1.1 Europe Cabazitaxel Consumption by Countries (2014-2019)
- 7.1.2 Europe Cabazitaxel Value by Countries (2014-2019)
- 7.2 Europe Cabazitaxel Consumption by Type
- 7.3 Europe Cabazitaxel Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cabazitaxel by Countries
- 8.1.1 Middle East & Africa Cabazitaxel Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Cabazitaxel Value by Countries (2014-2019)
- 8.2 Middle East & Africa Cabazitaxel Consumption by Type
- 8.3 Middle East & Africa Cabazitaxel Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Cabazitaxel Distributors
- 10.3 Cabazitaxel Customer
11 Global Cabazitaxel Market Forecast
- 11.1 Global Cabazitaxel Consumption Forecast (2019-2024)
- 11.2 Global Cabazitaxel Forecast by Regions
- 11.2.1 Global Cabazitaxel Forecast by Regions (2019-2024)
- 11.2.2 Global Cabazitaxel Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Cabazitaxel Forecast by Type
- 11.8 Global Cabazitaxel Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi
- 12.1.1 Company Details
- 12.1.2 Cabazitaxel Product Offered
- 12.1.3 Sanofi Cabazitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi News
- 12.2 Tapi Teva
- 12.2.1 Company Details
- 12.2.2 Cabazitaxel Product Offered
- 12.2.3 Tapi Teva Cabazitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Tapi Teva News
- 12.3 Fuan Pharmaceutical Group
- 12.3.1 Company Details
- 12.3.2 Cabazitaxel Product Offered
- 12.3.3 Fuan Pharmaceutical Group Cabazitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Fuan Pharmaceutical Group News
- 12.4 Fujian Yewpark Biological
- 12.4.1 Company Details
- 12.4.2 Cabazitaxel Product Offered
- 12.4.3 Fujian Yewpark Biological Cabazitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Fujian Yewpark Biological News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cabazitaxel . Industry analysis & Market Report on Cabazitaxel is a syndicated market report, published as Global Cabazitaxel Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Cabazitaxel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
